Mammals use distances and directions from local objects to calculate trajectories during navigation but how such vectorial operations are implemented in neural representations of space has not been determined. Here we show in freely moving mice that a population of neurons in the medial entorhinal cortex (MEC) responds specifically when the animal is at a given distance and direction from a spatially confined object. These 'object-vector cells' are tuned similarly to a spectrum of discrete objects, irrespective of their location in the test arena. The vector relationships are expressed from the outset in novel environments with novel objects. Object-vector cells are distinct from grid cells, which use a distal reference frame, but the cells exhibit some mixed selectivity with head-direction and border cells. Collectively, these observations show that object locations are integrated in metric representations of self-location, with specific subsets of MEC neurons encoding vector relationships to individual objects.
words, limit 150)Mammals use distances and directions from local objects to calculate trajectories during navigation but how such vectorial operations are implemented in neural representations of space has not been determined. Here we show in freely moving mice that a population of neurons in the medial entorhinal cortex (MEC) responds specifically when the animal is at a given distance and direction from a spatially confined object. These 'object-vector cells' are tuned similarly to a spectrum of discrete objects, irrespective of their location in the test arena. The vector relationships are expressed from the outset in novel environments with novel objects. Object-vector cells are distinct from grid cells, which use a distal reference frame, but the cells exhibit some mixed selectivity with head-direction and border cells. Collectively, these observations show that object locations are integrated in metric representations of self-location, with specific subsets of MEC neurons encoding vector relationships to individual objects. H.
Layer II of the medial entorhinal cortex (MEC) contains two principal cell types: pyramidal cells and stellate cells. Accumulating evidence suggests that these two cell types have distinct molecular profiles, physiological properties, and connectivity. The observations hint at a fundamental functional difference between the two cell populations but conclusions have been mixed. Here, we used a tTA-based transgenic mouse line to drive expression of ArchT, an optogenetic silencer, specifically in stellate cells. We were able to optogenetically identify stellate cells and characterize their firing properties in freely moving mice. The stellate cell population included cells from a range of functional cell classes. Roughly one in four of the tagged cells were grid cells, suggesting that stellate cells contribute not only to path-integration-based representation of self-location but also have other functions. The data support observations suggesting that grid cells are not the sole determinant of place cell firing.
Circulating tumor DNA is a promising biomarker to monitor tumor load and genome alterations. We explored the presence of circulating tumor DNA in multiple myeloma patients and its relation to disease activity during long-term follow-up. We used digital droplet polymerase chain reaction analysis to monitor recurrent mutations, mainly in mitogen activated protein kinase pathway genes NRAS, KRAS and BRAF. Mutations were identified by next-generation sequencing or polymerase chain reaction analysis of bone marrow plasma cells, and their presence analyzed in 251 archived serum samples obtained from 20 patients during a period of up to 7 years. In 17 of 18 patients, mutations identified in bone marrow during active disease were also found in a time-matched serum sample. The concentration of mutated alleles in serum correlated with the fraction in bone marrow plasma cells (r=0.507, n=34, P<0.002). There was a striking covariation between circulating mutation levels and M protein in ten out of 11 patients with sequential samples. When relapse evaluation by circulating tumor DNA and M protein could be directly compared, the circulating tumor DNA showed relapse earlier in two patients (3 and 9 months), later in one patient (4 months) and in three patients there was no difference. In three patients with transformation to aggressive disease, the concentrations of mutations in serum increased up to 400 times, an increase that was not seen for the M protein. In conclusion, circulating tumor DNA in myeloma is a multi-faceted biomarker reflecting mutated cells, total tumor mass and transformation to a more aggressive disease. Its properties are both similar and complementary to M protein.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.